This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB07747/identifier/chemspider/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07747/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07747/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07747/identifier/pubchem-substance/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07747/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07747
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07747 n14:DB07747
dcterms:title
(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE
adms:identifier
n7:9549217 n8:99444218 n9:DB07747 n10:F83 n13:7828137
n3:IUPAC-Name
n4:271B625C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6262-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6261-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B625E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B625F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6260-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B625A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6258-363D-11E5-9242-09173F13E4C5 n4:271B625B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6259-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6268-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6269-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B6263-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6264-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6266-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6265-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6267-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B626E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6270-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6271-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B626D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B626C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B626F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B625D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B626A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B626B-363D-11E5-9242-09173F13E4C5